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Summary: Carnitine was determined radioenzymatically in the plasma of 415 hospital employees involved in
a screening programme for prevention of major cardiovascular risks. A reference population (N = 340) was
extracted after excluding subjects with hypertension, diabetes mellitus or treatment for hypercholesterolaemia.
This population showed a Gaussian distribution for total and free carnitine concentrations both in females
and males but not for acyl carnitine or the acyl/free ratio. Females had lower total and free carnitine
concentrations but a higher ratio of acyl/free carnitine than males. These differences were not detectable in
older subjects (35 years for the acyl/free ratio, 45 years for total and free carnitine concentrations). Females
with a body mass index > 28 had a lower acyl/free ratio than their respective controls. The differences in
carnitine concentrations indicate that sex and age should be matched in patients or experimental groups and
controls in studies involving carnitine plasma concentrations.
Introduction _ , , . , , , . · · ιPublished data on carnitine concentrations in normal
Carnitine (3-hydroxy-4-trimethylaminobutanoate) is adult subjects comprise only small sample populations
required for the transport of long chain acyl moieties (14). We therefore took the opportunity to study the
into the mitochondria, and for buffering the intra- plasma carnitine concentrations in a cohort of 415
mitochondrial acyl-CoA/CpA ratio (1). Carnitine de- female and male hospital employees freely attending
ficiency either results from primary genetic defects or the hospital prevention centre during a screening pro-
from other genetic or acquired disorders, drug treat- gramme for the detection of the major risk factors
ments (including diet) or treatment leading to carni- for cardiovascular disease. The aim of this study was
tine loss (2 —7). Severe carnitine deficiency may result to determine carnitine concentrations in a reference
in myopathy (including cardiomyopathy), hepatic en- population for ambulatory patients in dependence on
cephalopathy and lipid storage in liver and muscle. age and sex.
Hypercarnitinaemia has been described in some pa-
tients with liver cirrhosis (8 — 10), in undialysed pa- M t * Is
tients with chronic renal insufficiency (11) and in
patients treated with lipid lowering drugs (12), or in £Caraitin^
. , , . j ' . . , . " . (Buchs, Switzerland); acetyl-Co A (tnhthium salt) and carnitine
rare congenital disorders like carnitine palmitoyl acetyl transferase (EC 2.3.1.7) from Boehringer Mannheim
transferase1) deficiency (13). (Rotkreuz, Switzerland). N-Ethylmaleimide, HEPES (2-[4-(hy-
droxyethyl)-piperazinylj-(l)-ethansulphonic acid) and the ion
exchange resin DOWEX 2X8, 200-400 mesh, in the Cl~ form
κ £ were from Merck (Zurich Switzerland).
Carnitine acetyl-transferase (EC 2.3.1.7) [Acetyl-1 -I4C] coenzyme A specific activity 1.92 MBq/mmol was
Carnitine palmitoyl-transferase (EC 2.3.1.21) obtained from Dupont (Geneva, Switzerland).
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Methods
Subjects
Subjects were hospital employees participating in a screening
programme for the detection of major risk factors for ischaemic
heart diseases (Lausanne, CHUV, Switzerland, 8-28 Novem-
ber 1990) organized in our university hospital. They arrived
independently at the centre between 11 am and 8pm. Fasting
was not a prerequisite.
Informed consent was obtained from each subject before blood
sampling. The study was approved by the local ethical com-
mittee.
Collection of specimens
Blood samples (2.7 ml) were drawn from an antecubital vein
after a 10 minutes rest, into lithium heparinate tubes (Sarstedt
AG, Sevelen, Switzerland) in the sitting position. Blood was
centrifuged, and the plasma was frozen at -80°C within 4
hours after sampling.
Samples (415 out of 1397) were randomly assigned for carnitine
determination.
Assays and statistics
Free carnitine was determined in the thawed plasma according
to a modified radioenzymatic method (15) without deproteini-
sation. The reaction mixture contained, in a final volume of
220 μΐ, 2.3 MBq/1 [14C-acetyl]CoA in 0.31 mmol/1 acetyl-CoA,
500 μιηοΐ N-ethylmaleimide (16), 103 mmol/1 HEPES pH 6.7,
1.45 kU/1 carnitine acetyl-transferase and 100 μΐ of prediluted
sample (1/10 with H2O, by vol.) or standards of L-carnitine. A
suspension of Dowex anion exchange resin (300 μΐ; 1 + 1 with
H2O by weight) was then added, the mixture vortexed 20
seconds and placed on ice to improve reproducibility. Mixing
was repeated twice at 5 min intervals. After centrifugation (4 °C,
10 rain, 8000 g), 300 μΐ of the supernatant was added to 10 ml
of Aquasol (Dupont International S.A) and assayed for radio^
activity in a liquid scintillation counter (Tricarb 2500, Canberra
Packard, Switzerland). A blank was run in parallel for correc-
tion of non-specific supernatant radioactivity.
Total carnitine (free and esterified) was determined as described
above except that 500 μΐ of the prediluted sample (1/10, by
vol.) was added to 100 μΐ 0.6 mol/1 KOH and allowed to stand
at 56 °C for 1 hour. pH was adjusted to 6.7 with 0.5 mmol/1
HC1 and HEPES 2.5 mol/1 pH 6.7. The total carnitine concen-
tration of the sample was calculated from the standard curve
of free carnitine, taking into account the dilution. Acylcarnitine
concentration was calculated from the difference of total and
free carnitine. The acyl to free ratio (acyl/free) was calculated
as mol/mol.
Intraserial imprecision (N = 8) was 2.7% and 1.8% for total
(57 μπιοΐ/ΐ) and free (43 μηιοΐ/ΐ) carnitine, respectively. Coeffi-
cients of variation of the day to day imprecision were assessed
with pools of serum and were less than 7% for total and free
carnitine.
Other clinical chemistry quantities were assayed on a Hitachi
717 (Boehringer, Rotkreuz, Switzerland) according to the rec-
ommendations of the Swiss Society of Clinical Chemistry or
IFCC, the enzyme activities being measured at 37 °C.
The body mass index was calculated as weight(kg)/[height(m)]2.
The distribution pattern was assessed by comparing the group
frequencies with the theoretical Gaussian or log-normal distri-
bution with the Kolmogorov Smirnov and the χ2 tests. Compar-
isons between groups were made with the Mann-Whitney test,
and correlations were tested with the Spearman rank correlation
test.
Results
Samples were analysed from 180 females and 160
males; none was hypertensive or diabetic, and none
was receiving treatment for hypercholesterolaemia.
In both sexes, the total and free carnitine concentra-
tions were compatible with a Gaussian distribution
(figs. 1 and 2); acyl carnitine and the acyl/free ratio
differed significantly from this distribution. The acyl/
free ratio could be normalised by the log transfor-
mation in the males only. Thus percentiles and non-
parametric tests were used for evaluating these quan-
tities.
Mean values for total and free carnitine were signif-
icantly higher in the males than in the females. Fe-
males had significantly higher median values for acyl
carnitine and acyl/free ratio than males (tab. 1). Total
and free carnitine tended to increase with age in both
sexes. No age effect was observed on acyl carnitine
or on the acyl/free ratio in both sexes (tab. 2). Before
45 years of age total carnitine levels were found to be
lower in females than in males (tab. 2). The same is
true for free carnitine. No more differences were ob-
served after this age. The acyl/free ratio was higher
in females than in males whatever the age, but the
differences were statistically significant only before
the age of 35 years.
In the females, total and free carnitine was lower in
the group with a body mass index < 28 [Ml]
(N = 157, 34% > 44 years of age) than in the group
with a body mass index > 28 [M2] (N = 23, 43%
> 44 years of age): median total carnitine, Ml = 38
andM2 = 42μιηο1/1,ρ < 0.01; median free carnitine,
Ml = 30 and M2 = 37 μιηοΐ/l, ρ < 0.001. The me-
dian acyl/free ratio was lower in the group with a
body mass index > 28 (0.15) than in the group with
a body mass index < 28 (0.20), ρ < 0.005. These
differences cannot be explained by difference in group
age. No such differences were seen in the male groups.
Among the frequently assayed clinical chemistry com-
ponents (aspartate aminotransferase, alandne amino-
transferase, lactate dehydrogenase, creatine kinase, γ-
glutamyl-transferase, alkaline phosphatase, biUrubin
(direct and total), lipase, amylase, albumin, iron, uric
acid, urea and creatinine) only a few significant cor-
relations with the carnitine concentrations were
found. Significant Spearman rank correlation coeffi-
cients did not exceed 0.24 except for the correlation
of uric acid with free (0.41) and total (0.41) carnitine
in normouricaemic females.
Female participants with cholesterol values below 6.5
mmol/1 [FC1] (N = 147, 26% over 44 years old) had
lower total carnitine and free carnitine concentrations
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Fig. 1. Total carnitine: Normal probability plot for total car-
nitine in the reference population according to sex. The
distribution fits the Gaussian model (Kolmogorov-Smir-
noffand χ2 tests).
Ο: females, 4-: males.
Free carnitine [ umol/1]
Fig. 2. Free carnitine: Normal probability plot for free carni-
tine in the reference population according to sex. The
distribution fits the Gaussian model (Kolmogorov-Smir-
noff and χ2 tests).
O: females, +: males.
Tab. 1. Reference values of plasma carnitine concentration: Concentrations of carnitine (μιηοΐ/ΐ) in females and males and acyl/
free ratio (mol/mol) in the reference population.
Ν = number of specimens; Min = minimal value; Max = maximal value; P2.5 = 2.5th percentile; P97.5 = 97.5lh






















































































than female participants with cholesterol above 6.5
mmol/1 [FC2] (N = 71, 75% over 44 years old): me-
dian total carnitine, FC1 = 38 and FC2 = 42 μιηοΐ/ΐ,
ρ < 0.002; median free carnitine FC1 = 31 and FC2
= 35 μπιοΐ/ΐ, ρ < 0.001. In the group of females with
cholesterol values above 6.5 mmol/1, acyl/free ratio
was higher when the cholesterol/HDL-cholesterol ra-
tio was below 5 (N = 44, acyl/free median 0.2) than
when the cholesterol/HDL-cholesterol exceeded 5
(N = 23, acyl/free median 0.15, ρ < 0.05, 91% over
44 years old).
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Tab. 2. Carnitine concentrations and age: Percentiles for carnitine concentrations and acyl/free ratio in females and males
according to age.
N = number of specimens; Min = minimal value; Max = maximal value; P2.5 = 2.5th peicentile; P97.5 = 97.5*






















































































































































































Male participants with cholesterol values below 6.5
mmol/1 (N = 138, 24% over 44 years old) had lower
values of total carnitine (median value 43 μιηοΐ/l)
than male participants with cholesterol above 6.5
mmol/1 (N = 59 median value total carnitine: 47
μπιοΐ/l, ρ < 0.05, 47% over 44 years old).
There was no linear correlation between carnitine and
systolic or diastolic blood pressure. No difference of
carnitine concentrations was observed between smok-
ers (1 or more cigarettes per day) and non-smokers.
Discussion
Carnitine concentrations obtained in our reference
population compared well with the data of most other
authors, which were, however, obtained on smaller
samples of males and females (8, 9, 14, 17, 18). Some
authors (19-21) have reported higher total and free
carnitine concentrations. As already discussed by
Schmidt-Sommerfeld & Penn (19), the total carnitine
concentration might be underestimated, because the
calculation of total carnitine is based on free carnitine
standards. The reasons for this effect are not clear. It
can lead to calculate free carnitine concentrations that
are higher than the total carnitine concentration in
some samples. In our study, such rare cases were
discarded. Total and free carnitine concentrations
were higher in males than in females, confirming the
previously reported observations (14, 18 —21). In ac-
cordance with some authors (20) we found higher
acyl/free ratio in females than in males. We are not
aware of any endocrinological data that would explain
the lower carnitine concentrations found by us in
premenopausal women. This fact and the differences
observed on carnitine concentrations with age suggest
that sex and age must be considered in studies in-
volving carnitine.
All correlations observed between carnitine fractions
and other clinical chemistry quantities, although sta-
tistically significant, account only for up to 5% of the
total variance and thus can be considered as not
clinically relevant. With respect to uric acid, creatinine
and albumin, the correlations were probably due to
the nutritional state, as fasting was not a prerequisite.
These correlations may also reflect a general dietary
effect in a well nourished population (22-24). Such
factors have however been shown not to affect the
intraindividual variation of carnitine concentrations
(14). The correlation between total and free carnitine
and uric acid has already been observed in undialysed
patients with chronic renal insufficiency (11).
In contrast to data of patients with liver cirrhosis (9),
the γ-glutamyl transferase was inversely correlated
with the acyl/free ratio in females (not in males) in
our healthy ambulatory population.
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Our results clearly indicate that when plasma carnitine
concentrations are compared in adults, the groups
have to be matched at least for sex and, particularly
in females, for age.
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